Shunji Kusaka

• Topic 1 Opening
  吳為吉 Wei-Chi WuTaiwan Moderator

  賴旗俊 Chi-Chun LaiTaiwan Moderator
• Evolving Vitreoretinal Surgery with ARTEVO 850 and EVA Nexu
  Shunji Kusaka Speaker

  吳為吉 Wei-Chi WuTaiwan Moderator

  賴旗俊 Chi-Chun LaiTaiwan Moderator
• Panel Discussion
• Seizing the Golden Window of Myopia Intervention: The Clinical Advantages of ZEISS MyoCare
  林慧茹 Hui-Ju LinTaiwan Moderator Advances in Artificial Intelligence Models and Algorithms in Amblyopia and Strabismus Review of Artificial Intelligence (AI) models that detect strabismus and amblyopia risk factors from smartphone photos, videos, and images, facilitating large-scale, accessible community screening. Discussion on how AI is personalizing amblyopia therapy, thereby maximizing efficacy and engagement. Critical appraisal of the requirements for clinical validation, regulatory approval, and the ethical integration of these AI tools into standard ophthalmic practice. AI is poised to fundamentally reshape the management of strabismus and amblyopia by introducing unprecedented levels of objectivity, accessibility, and personalization. the knowledge to understand, evaluate, and eventually integrate these powerful technologies into their practice to improve patient outcomes. AI screening and diagnosis to treatment optimization and monitoring.

  梁智凱 Zhi-Kai-Liang Speaker
• Panel Discussion